Hypoglycemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypoglycemia}} | {{Hypoglycemia}} | ||
{{CMG}} {{MAD}} | {{CMG}} {{AE}} {{MAD}} | ||
==Overview== | ==Overview== | ||
Revision as of 17:10, 20 July 2017
|
Hypoglycemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoglycemia surgery On the Web |
|
American Roentgen Ray Society Images of Hypoglycemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Surgical removal of the insulinoma is the treatment of choice and resection of metastatic liver disease.
Surgery
- Surgical removal of the insulinoma is the treatment of choice:[1]
- Enucleation of the insulinoma
- Partial distal pancreatectomy
- Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.[2]
- Recurrence is more common in the patients with MEN1.
- Hepatic resection is indicated for the treatment of metastatic liver disease if general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.
References
- ↑ Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin Proc. 66 (7): 711–9. PMID 1677058.
- ↑ Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH (1991). "Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach". Surgery. 110 (6): 998–1004, discussion 1004-5. PMID 1684067.